Supply Chain

Indian drugmaker Claris Injectibles, a subsidiary of Claris Lifesciences Limited, earned Food and Drug Administration approval for its tobramycin injectable medication.

The Food and Drug Administration issued two draft guidances Thursday that aim to provide a flexible, efficient approach for regulating individualized genomic testing, in accordance with President Barack Obama's Precision Medicine Initiative.

Belgian drugmaker Ablynx holds high hopes for its experimental drug to treat rheumatoid arthritis after seeing strong results in a recent clinical trial, according to Reuters.

Pfizer has vowed to follow a written code of conduct for the marketing of opioids, according to The Washington Post.

The Food and Drug Administration recently approved Edenbridge Pharmaceuticals' ethacrynic acid tablets.

Prism Medical & Design, based in Coral Springs, Fla., earned approval from the Food and Drug Administration for its ProteXsureSafety Capsule System.

Existing national programs for detecting polio could prove beneficial in globally targeting a neurological condition linked to Zika, according to Reuters.

A global shortage of a radioactive substance used in exercise stress tests is linked to a 10 percent increase in heart catheterizations, according to a study published in the journal JAMA Cardiology.

Sanofi entered into a research and development deal with the U.S. Army to accelerate the development of a Zika vaccine, according to Reuters.

San Diego-based NuVasive will acquire Biotronic NeuroNetwork for $98 million in cash.